| human | Q5 |
| P496 | ORCID iD | 0000-0003-4019-9328 |
| P108 | employer | University Hospital Erlangen | Q1544159 |
| P106 | occupation | researcher | Q1650915 |
| Q33848895 | 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy |
| Q35957063 | A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density |
| Q39437211 | Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers |
| Q34613673 | Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study |
| Q35218520 | Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy |
| Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
| Q40075679 | Association between mammographic density and pregnancies relative to age and BMI: a breast cancer case-only analysis |
| Q37684672 | Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. |
| Q41706112 | Association of molecular subtypes with breast cancer risk factors: a case-only analysis |
| Q46115524 | Body mass index and breast cancer survival: a Mendelian randomization analysis |
| Q43122429 | Breast cancer risk assessment in a mammography screening program and participation in the IBIS-II chemoprevention trial |
| Q39978884 | Breast volumetry using a three-dimensional surface assessment technique |
| Q36245595 | Characterizing mammographic images by using generic texture features |
| Q37802075 | Comparison between distally based peroneus brevis and sural flaps for reconstruction of foot, ankle and distal lower leg: an analysis of donor-site morbidity and clinical outcome. |
| Q53204537 | Comparison of cortical and cancellous bone remodeling of the pelvis after press-fit cup total hip arthroplasty dependent on patient and prosthesis-specific characteristics: a computed tomography-assisted osteodensitometry study in vivo. |
| Q34428536 | Comparison of reoperation rates, perioperative outcomes in women with endometrial cancer when the standard of care shifts from open surgery to laparoscopy |
| Q33775316 | Correlation of mammographic density and serum calcium levels in patients with primary breast cancer |
| Q43003217 | Effects of intramuscular testosterone undecanoate on body composition and bone mineral density in female-to-male transsexuals |
| Q35815412 | Endometriosis as a risk factor for ovarian or endometrial cancer - results of a hospital-based case-control study |
| Q36720821 | Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors |
| Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
| Q45006117 | Factors influencing breast changes after pregnancy |
| Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
| Q114182808 | Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element |
| Q36422109 | Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium |
| Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
| Q29417100 | Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer |
| Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
| Q46188099 | HER2 and TOP2A amplification in a hospital-based cohort of breast cancer patients: associations with patient and tumor characteristics |
| Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
| Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
| Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
| Q36086247 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus |
| Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
| Q114184688 | Incorporating progesterone receptor expression into the PREDICT breast prognostic model |
| Q64279327 | Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk |
| Q34074094 | Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment |
| Q29416989 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
| Q62583472 | Mammographic density as a risk factor for breast cancer in a German case–control study |
| Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
| Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
| Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
| Q42013702 | Polymorphisms in the RANK/RANKL genes and their effect on bone specific prognosis in breast cancer patients |
| Q62583470 | Pooled analysis of the prognostic relevance of progesterone receptor status in five German cohort studies |
| Q92055460 | Prediction and clinical utility of a contralateral breast cancer risk model |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q91832507 | Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts |
| Q92551866 | Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patients |
| Q57476250 | Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis |
| Q42512310 | Prognostic molecular markers and neoadjuvant therapy response in anthracycline-treated breast cancer patients |
| Q45756790 | Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis |
| Q33779487 | Progressive femoral cortical and cancellous bone density loss after uncemented tapered-design stem fixation |
| Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
| Q46518171 | Serotonin used as prognostic marker of urological tumors |
| Q42599064 | Shared decision-making in metastatic breast cancer: discrepancy between the expected prolongation of life and treatment efficacy between patients and physicians, and influencing factors |
| Q53160267 | Stress-related femoral cortical and cancellous bone density loss after collum femoris preserving uncemented total hip arthroplasty: a prospective 7-year follow-up with quantitative computed tomography. |
| Q91178389 | The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer |
| Q36137764 | The contributions of breast density and common genetic variation to breast cancer risk |
| Q53668741 | The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer. |
| Q92994868 | Two truncating variants in FANCC and breast cancer risk |
Search more.